Patents & Exclusivity of Drug Products in US Market
Patents & Exclusivity of Drug Products in US Market Patents …
Read more
Suitability Petitions for ANDAs
Suitability Petitions for ANDAs An ANDA suitability petition is …
Read more
US Vs EU - Q1 & Q2 Sameness Requirements for Regulatory Filings
Q1 & Q2 Sameness Requirements for Parenteral Generic Product Filings - US Vs EU …
Read more
What is European Public Assessment Report (EPARs) and Periodic safety update reports (PSURs)?
What is European Public Assessment Report (EPARs) and Periodic safety update reports …
Read more
Markeeting Authorizations (MA) Validity and Renewal in European Union
Marketing Authorizations (MA) Validity and Renewal in EU – Interesting Facts …
Read more
USFDA’s User Fee Programs - PDUFA/MDUFA/GDUFA/BsUFA/ADUFA/AGDUFA
The User Fee programs help the Food and Drug Administration (FDA) to fulfill its mission of pro…
Read more
What is the difference between GDUFA and PDUFA?
Both GDUFA and PDUFA are US FDA’s User Fee programs, which help FDA to hire and retain sufficie…
Read more
What is the difference between Reference Listed Drug (RLD) and Reference Standard (RS) in Orange Book?
Reference Listed Drug (RLD): An RLD is the specific listed drug on which an ANDA applicant reli…
Read more
RTR - Refuse to Receive standards for ANDA and PAS Filings - USFDA
When an applicant submits an ANDA to agency, OGD (Office Generic Drug…